2022 IBTRS Abstracts can be submitted from 8 November to 15 December 2021, has been extended to 15 January 2022.
The Late-Breaker Abstract submission period 16 January – 1 February 2022.
A Template for the 2022 IBTRS Symposium is available to you HERE
- Please note: Submission of an abstract for 2022 IBTRS indicates your consent for the abstract to be available within the Symposium Abstract Book and IBTRS Virtual space.
- Submitted abstract should be based on new data that has not previously presented or published.
- All abstracts will be screened for plagiarism using automated online tools.
- The Organizing Committee reserves the right to reject abstracts if there are any ethical concerns regarding plagiarism or the presentation of published materials. All abstracts will be reviewed and submitting authors will have an opportunity to revise abstracts within the SWMP/IBTRS website portal (dashboard).
Abstract quick start guide
Abstracts can be submitted online at https://swmprogramua.com/ibtrs-registration/. A step-by-step explanation of the submission process can be found on the Symposium page.
English is the international language of the scientific community. To support the development of English language skills and to ensure accurate translation of all submitted abstracts, you are recommended to submit your abstract in both English and Ukrainian.
If you need assistance in translating your abstract into English, please submit the abstract in Ukrainian and we will translate it.
Participants from Ukraine must provide the Ukrainian text of the abstract even if they have an English version. For foreign participants, please submit all materials in English.
File name: please use the following file naming convention: “Lastname_Firstname_2022 IBTRS_abstract”.
Abstract titles should be succinct and informative. Do not submit abstract title in all capital letters.
Authors and Affiliation
Please follow standard international authorship rules for manuscripts:
- Everyone who is listed as an author should have made a substantial, direct, intellectual contribution to the work. For example (in the case of a research report) they should have contributed to the conception, design, analysis and/or interpretation of data. Honorary or guest authorship is not acceptable. Acquisition of funding and provision of technical services, patients, or materials, while they may be essential to the work, are not in themselves sufficient contributions to justify authorship.
- Everyone who has made substantial intellectual contributions to the work should be an author. Everyone who has made other substantial contributions should be acknowledged.
- The authors should decide on the order of authorship together.
- When research is done by teams whose members are highly specialized, individual’s contributions and responsibility may be limited to specific aspects of the work.
- All authors should participate in writing the manuscript by reviewing drafts and approving the final version.
- One author should take primary responsibility for the work as a whole even if he or she does not have an in-depth understanding of every part of the work.
The primary author should assure that all authors meet basic standards for authorship and should prepare a concise, written description of their contributions to the work, which has been approved by all authors. This record should remain with the sponsoring department.
- Please double check that the names of author(s) and their affiliation(s) are correctly spelled and formatted, with appropriate capitalization and punctuation.
- The presenting author should be underlined, the name should be abbreviated, patronymic, academic degree or academic title is not required.
- Names and surnames cannot be edited by the submitter after abstract acceptance and will be published exactly as inputted. The IBTRS Organizing Committee will need to be contacted for any further changes.
- The IBTRS organizers cannot be held responsible for errors in either author or affiliation information.
Please note: Organizing Committee reserves the right to correct the names of institutions in Ukrainian and English in accordance with their official name and to abbreviate long well-known names by adding them to the list of abbreviations in the 2022 IBTRS Abstract Book.
To ensure direct and timely communication with the symposium organizers, presenting author must provide a personal email for correspondence. Please do not use the email of the institution or department in your abstract.
Abstract should be written clearly and divided into four sections with the following subheadings:
- Introduction. Please clearly state the background and context of research and its goals. This section should be specific to the study, contain facts and identify gaps in existing knowledge. The aim of the study and/or hypothesis must be clearly stated.
- Methods. The Methods section should provide minimum required information on the research setting, data collection and analytical methods used (wet lab, data), ethical issues and biosafety requirements. You should clearly define the used methods and avoid generalizations such as “epidemiological”, “bacteriological”, “statistical”, “standard methods” and so on.
- Results. Results presented in the abstract should be original data not previously published or presented. All results should be consistent with the aim of the studies and the methods described in the “Methods” section. We recommend that you include in this section only the data of your research; there is no need to discuss literature data in this section. In the context of descriptive and qualitative research, briefly list the relevant results. For analytical studies, provide quantitative data, including exposure effects and confidence intervals. Please indicate clear indicators of variation, statistical significance (p-value), etc. Only abstracts with results or preliminary data will be considered. Abstracts on studies that are only planned and do not have at least preliminary data will not be considered.
- Conclusions. Conclusions should be based on factual data and formed directly from the results of your studies. Please clearly summarize and discuss the value of the data presented. All your statements must be supported by the data described in the “Results” section. Your conclusions should relate to the introduction, aim and/or hypothesis of the study. Additionally, please indicate in this section your contribution to the study of this issue, what is the importance of your research, for example, to improve the legislation, methodology, measures to prevent or solve the described problem, etc. In addition, you are expected to describe your next steps and future directions of the research.
Pictures/Graphs/Tables are not allowed in the abstract.
Authors are required to enter 3-5 keywords to better define the abstract content.
ALL CAPS for text (other than abbreviations or acronyms) are not allowed. The abstract text may not be longer than a maximum of 350 words.
The following scientific rules apply (examples in brackets):
- Recommended formatting options for the abstract text: 10 pt Arial font, 1.15 line spacing, left side alignment.
- Latin expressions in texts have to be written in italics (e.g., in vitro/in vivo, ad hoc, ex officio).
- Taxonomic names must be italicized (e.g., Staphylococcus aureus, Clostridium difficile).
- After the first mention in the text, the name of the genus should be shortened (e.g., S. aureus, C. difficile). Leave only the first letter in the genus name.
- Non-systematic names (e.g., plural): lower case and not italicized (e.g., group A streptococci, mycobacteria, chlamydiae).
- Generic drug names: lower case (e.g., penicillin).
- Do not use brand names in titles; product names are allowed but should be avoided in the title.
- Only common abbreviations may be used without definition (e.g., DNA, PCR, COVID-19). Please make sure that you specify all other abbreviations in full at the first mention in the text. Additionally, please give in full the names and terms in the title of the abstract.
- Authors are required to enter 3-5 keywords to better define the abstract content.
It is desirable that the abstract is submitted by the author who will present the work. After submission, a confirmation by email will be sent to the submitter (please make sure to state your correct email address!). Only submitter will be notified by email and is responsible for obtaining permission for submission and presentation of the abstract from all co-authors and any relevant stakeholders. All correspondence regarding acceptance or rejection, including further information on the mode of presentation etc. will be sent to the submitter/presenting author.
Following 2022 IBTRS, a certificate of participation will be sent to the presenting author only.
Certificates will not be awarded to authors that are not present during their live oral/poster sessions at 2022 IBTRS, or whose posters do not comply with the requirements for size and format.
If you have any questions or need any assistance, please do not hesitate to contact us at firstname.lastname@example.org.